To receive regular updates, including all of CLINUVEL’s announcements, you can subscribe to our email database here.

A selection of press coverage is listed below

Title Link
Philippe Wolgen of CLINUVEL PHARMACEUTICALS driven by competition The Australian
New Treatment Inspires Hope for the Battle Against Sun Allergy Good Morning America
Drug Offers Hope Against Disease Where Sunlight Causes Pain Health Day
Implanted drug improves tolerance of sunlight in rare condition Reuters
11-Year-Old ‘Allergic’ to Sunlight Good Morning America
Out of the shadows (content only available in the USA) NBC Dateline
Wanneer de zon een hel wordt VTM News
CLINUVEL To Build Vitiligo Pipeline And Commercial Presence The Pink Sheet
CLINUVEL’s subisidiary develops drug candidate for vitiligo Biospectrum Asia
Sonne im Herzen SRF Aescherbach
INTERVIEW: CLINUVEL’s Philippe Wolgen on Scenesse and the patient factor Scrip
Interview – CLINUVEL scores at last, courtesy of patient lobby EP Vantage
Exposure to sunlight burns my skin – now I can come out the shadows thanks to new drug Bournemouth Echo
CLINUVEL’s tanning agent nears approval for porphyria Nature Biotech
Aus dem Schatten hervortreten NZZ